Cargando…
Improving the Transduction of Bone Marrow–Derived Cells with an Integrase-Defective Lentiviral Vector
In lentiviral vector (LV) applications where transient transgene expression is sufficient, integrase-defective lentiviral vectors (IDLVs) are beneficial for reducing the potential for off-target effects associated with insertional mutagenesis. It was previously demonstrated that human RPE65 mRNA exp...
Autores principales: | Pay, S. Louise, Qi, Xiaoping, Willard, Jeffrey F., Godoy, Juliana, Sankhavaram, Kavya, Horton, Ranier, Mitter, Sayak K., Quigley, Judith L., Chang, Lung-Ji, Grant, Maria B., Boulton, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806075/ https://www.ncbi.nlm.nih.gov/pubmed/29160102 http://dx.doi.org/10.1089/hgtb.2017.082 |
Ejemplares similares
-
Use of Integrase-Minus Lentiviral Vector for Transient
Expression
por: Farazmandfar, Touraj, et al.
Publicado: (2012) -
Integrase deficient lentiviral vector: prospects for safe clinical applications
por: Yew, Chee-Hong Takahiro, et al.
Publicado: (2022) -
Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
por: Michelini, Zuleika, et al.
Publicado: (2020) -
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021) -
Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014)